Ignite Creation Date:
2025-12-24 @ 5:01 PM
Ignite Modification Date:
2026-01-02 @ 3:28 AM
Study NCT ID:
NCT03469050
Status:
TERMINATED
Last Update Posted:
2021-10-20
First Post:
2018-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rifaximin Delayed Release for the Prevention of Recurrent Acute Diverticulitis and Diverticular Complications.
Sponsor:
Alfasigma S.p.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-02
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-22
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-06
First Submit QC Date:
None
Study First Post Date:
2018-03-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-13
Last Update Post Date:
2021-10-20
Last Update Post Date Type:
ACTUAL